TipRanks
Invex Therapeutics Ltd. (AU:IXC)
ASX:IXC
Australian Market
Want to see AU:IXC full AI Analyst Report?

Invex Therapeutics Ltd. (IXC) Financial Statements

2 Followers

Invex Therapeutics Ltd. Financial Overview

Invex Therapeutics Ltd.'s market cap is currently AU$7.52M. The company's EPS TTM is AU$-0.018; its P/E ratio is -5.56; and it has a dividend yield of 248.40%. Invex Therapeutics Ltd. is scheduled to report earnings on August 31, 2026, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 26Jun 25Jun 24Jun 23Jun 22
Income Statement
Total RevenueAU$ 0.00AU$ 229.08KAU$ 1.21MAU$ 459.08KAU$ 182.25K
Gross ProfitAU$ 0.00AU$ 229.08KAU$ 1.21MAU$ 459.08KAU$ 182.25K
Operating IncomeAU$ -1.54MAU$ -709.30KAU$ -2.13MAU$ -8.55MAU$ -4.03M
EBITDAAU$ -1.54MAU$ 0.00AU$ -720.37KAU$ 337.94KAU$ -4.14M
Net IncomeAU$ -1.35MAU$ -476.87KAU$ -1.64MAU$ -7.75MAU$ -3.95M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 4.02MAU$ 5.38MAU$ 6.03MAU$ 22.47MAU$ 29.34M
Total AssetsAU$ 4.06MAU$ 5.47MAU$ 6.12MAU$ 22.80MAU$ 29.49M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -1.52MAU$ -5.38MAU$ -6.03MAU$ -22.47MAU$ -29.34M
Total LiabilitiesAU$ 153.47KAU$ 220.59KAU$ 431.63KAU$ 1.57MAU$ 1.00M
Stockholders' EquityAU$ 3.91MAU$ 5.25MAU$ 5.69MAU$ 21.23MAU$ 28.48M
Cash Flow
Free Cash FlowAU$ -1.36MAU$ -652.57KAU$ -2.44MAU$ -6.87MAU$ -3.38M
Operating Cash FlowAU$ -1.36MAU$ -652.57KAU$ -2.44MAU$ -6.87MAU$ -3.38M
Investing Cash FlowAU$ -2.50MAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Financing Cash FlowAU$ 0.00AU$ 0.00AU$ -14.00MAU$ 0.00AU$ 0.00
Currency in AUD

Invex Therapeutics Ltd. Earnings and Revenue History

Invex Therapeutics Ltd. Debt to Assets

Invex Therapeutics Ltd. Cash Flow

Invex Therapeutics Ltd. Forecast EPS vs Actual EPS